Trials / Completed
CompletedNCT04108234
A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects
Safety, Tolerance and Pharmacokinetics of Hydrochloric Acid (R) -Ketamine Nasal Spray in Healthy Subjects: A Randomized, Double Blind, Placebo-Controlled Phase I Clinical Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HR071603 | HR071603 monotherapy ,nasal spray |
| DRUG | placebo | placebo,nasal spray |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2019-09-30
- Last updated
- 2022-06-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04108234. Inclusion in this directory is not an endorsement.